Trial Profile
The study about the prevalence of olfactory dysfunction related to allergic rhinitis and the effect by montelukast
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Jul 2020
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Allergic rhinitis; Olfaction disorders
- Focus Therapeutic Use
- 30 Dec 2014 New trial record